261 related articles for article (PubMed ID: 24419125)
1. Longitudinal serum testosterone, luteinizing hormone, and follicle-stimulating hormone levels in a population-based sample of long-term testicular cancer survivors.
Sprauten M; Brydøy M; Haugnes HS; Cvancarova M; Bjøro T; Bjerner J; Fosså SD; Oldenburg J
J Clin Oncol; 2014 Feb; 32(6):571-8. PubMed ID: 24419125
[TBL] [Abstract][Full Text] [Related]
2. The metabolic syndrome and disturbances in hormone levels in long-term survivors of disseminated testicular cancer.
Nuver J; Smit AJ; Wolffenbuttel BH; Sluiter WJ; Hoekstra HJ; Sleijfer DT; Gietema JA
J Clin Oncol; 2005 Jun; 23(16):3718-25. PubMed ID: 15738540
[TBL] [Abstract][Full Text] [Related]
3. Genetic variations associated with the effect of testicular cancer treatment on gonadal hormones.
Aschim EL; Oldenburg J; Kristiansen W; Giwercman A; Witczak O; Fosså SD; Haugen TB
Hum Reprod; 2014 Dec; 29(12):2844-51. PubMed ID: 25336703
[TBL] [Abstract][Full Text] [Related]
4. Gonadal status in male survivors following childhood brain tumors.
Schmiegelow M; Lassen S; Poulsen HS; Schmiegelow K; Hertz H; Andersson AM; Skakkebaek NE; Müller J
J Clin Endocrinol Metab; 2001 Jun; 86(6):2446-52. PubMed ID: 11397837
[TBL] [Abstract][Full Text] [Related]
5. Gonadal hormones in long-term survivors 10 years after treatment for unilateral testicular cancer.
Nord C; Bjøro T; Ellingsen D; Mykletun A; Dahl O; Klepp O; Bremnes RM; Wist E; Fosså SD
Eur Urol; 2003 Sep; 44(3):322-8. PubMed ID: 12932930
[TBL] [Abstract][Full Text] [Related]
6. Re: Longitudinal serum testosterone, luteinizing hormone, and follicle-stimulating hormone levels in a population-based sample of long-term testicular cancer survivors.
Richie JP
J Urol; 2015 Feb; 193(2):542. PubMed ID: 25617277
[No Abstract] [Full Text] [Related]
7. A study of the endocrine manifestations of hepatic cirrhosis.
Baker HW; Burger HG; de Kretser DM; Dulmanis A; Hudson B; O'Connor S; Paulsen CA; Purcell N; Rennie GC; Seah CS; Taft HP; Wang C
Q J Med; 1976 Jan; 45(177):145-78. PubMed ID: 769039
[TBL] [Abstract][Full Text] [Related]
8. Testosterone, LH and FSH in patients with treated testicular carcinomas.
Dunzendorfer U; Weber W
Horm Metab Res; 1978 Mar; 10(2):156-7. PubMed ID: 649040
[TBL] [Abstract][Full Text] [Related]
9. [Sperm, LH FSH, testosterone evaluation in patients with testicular cancer. Preliminary study].
Demkow T; Faundez R; Madej G
Ginekol Pol; 1998 Jun; 69(6):405-9. PubMed ID: 9695352
[TBL] [Abstract][Full Text] [Related]
10. Radiotherapy for rectal cancer is associated with reduced serum testosterone and increased FSH and LH.
Bruheim K; Svartberg J; Carlsen E; Dueland S; Haug E; Skovlund E; Tveit KM; Guren MG
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):722-7. PubMed ID: 18262088
[TBL] [Abstract][Full Text] [Related]
11. Associations between long-term serum platinum and neurotoxicity and ototoxicity, endocrine gonadal function, and cardiovascular disease in testicular cancer survivors.
Hjelle LV; Bremnes RM; Gundersen POM; Sprauten M; Brydøy M; Tandstad T; Wilsgaard T; Fosså SD; Oldenburg J; Haugnes HS
Urol Oncol; 2016 Nov; 34(11):487.e13-487.e20. PubMed ID: 27523611
[TBL] [Abstract][Full Text] [Related]
12. Hormonal predictors of prostate cancer.
Sofikerim M; Eskicorapci S; Oruç O; Ozen H
Urol Int; 2007; 79(1):13-8. PubMed ID: 17627161
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal Changes in Serum Levels of Testosterone and Luteinizing Hormone in Testicular Cancer Patients after Orchiectomy Alone or Bleomycin, Etoposide, and Cisplatin.
Bandak M; Jørgensen N; Juul A; Lauritsen J; Kier MGG; Mortensen MS; Daugaard G
Eur Urol Focus; 2018 Jul; 4(4):591-598. PubMed ID: 28753832
[TBL] [Abstract][Full Text] [Related]
14. Testicular function in poor-risk nonseminomatous germ cell tumors treated with methotrexate, paclitaxel, ifosfamide, and cisplatin combination chemotherapy.
Pectasides D; Pectasides E; Papaxoinis G; Skondra M; Gerostathou M; Karageorgopoulou S; Kamposioras C; Tountas N; Koumarianou A; Psyrri A; Macheras A; Economopoulos T
J Androl; 2009; 30(3):280-6. PubMed ID: 19136393
[TBL] [Abstract][Full Text] [Related]
15. [Serum testosterone, dihydrotestosterone, luteinizing hormone and follicle-stimulating hormone versus prostate specific antigen in patients with localized prostate adenocarcinoma who underwent radical prostatectomy. Radioimmunoassays measurements].
Bantis A; Zissimopoulos A; Athanasiadou P; Gonidi M; Agelonidou E; Strataki A; Matthaios D; Tsartsarakis A
Hell J Nucl Med; 2007; 10(1):56-61. PubMed ID: 17450256
[TBL] [Abstract][Full Text] [Related]
16. Serum testosterone, LH, and FSH in patients with testicular cancer before and after radio- and chemotherapy.
Berthelsen JG; Engelholm SA; von der Maase H; Rørth M
Scand J Urol Nephrol; 1983; 17(3):287-90. PubMed ID: 6316483
[TBL] [Abstract][Full Text] [Related]
17. [Dependence of serum hormones (T, FSH, LH) on morphometric testicular findings after chemo- and radiotherapy in patients with malignant testicular tumors].
Barth V; Schönfelder M
Zentralbl Allg Pathol; 1990; 136(5):439-42. PubMed ID: 2122615
[TBL] [Abstract][Full Text] [Related]
18. Early and late long-term effects of vasectomy on serum testosterone, dihydrotestosterone, luteinizing hormone and follicle-stimulating hormone levels.
Mo ZN; Huang X; Zhang SC; Yang JR
J Urol; 1995 Dec; 154(6):2065-9. PubMed ID: 7500459
[TBL] [Abstract][Full Text] [Related]
19. Multiple forms of hypogonadism of central, peripheral or combined origin in males with Prader-Willi syndrome.
Radicioni AF; Di Giorgio G; Grugni G; Cuttini M; Losacco V; Anzuini A; Spera S; Marzano C; Lenzi A; Cappa M; Crinò A
Clin Endocrinol (Oxf); 2012 Jan; 76(1):72-7. PubMed ID: 21718342
[TBL] [Abstract][Full Text] [Related]
20. Changes in circulating levels of immunoreactive follicle stimulating hormone, luteinizing hormone, and testosterone during sexual development in the rhesus monkey, Macaca mulatta.
Arslan M; Mahmood S; Khurshid S; Naqvi SM; Afzal MA; Baig SM
J Med Primatol; 1986; 15(5):351-9. PubMed ID: 3100808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
